top of page
News
We're thrilled to share the latest developments from our company.
Suche
ODI Pharma AB: Publication of half-year report 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available...
ODI Pharma
23. Feb. 20233 Min. Lesezeit
ODI Pharma receives approval from the Office for Registration of Medicinal Products in Poland
ODI Pharma AB (“ODI” or the “Company”) announces today that the Company has received approval from the Office for Registration of...
ODI Pharma
24. Jan. 20232 Min. Lesezeit
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
16. Dez. 20222 Min. Lesezeit
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 16 december 2022 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
16. Dez. 20222 Min. Lesezeit
ODI Pharma AB: Publication of interim report Q1 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report concerning the period July 2022 to September 2022. The report...
ODI Pharma
25. Nov. 20223 Min. Lesezeit
ODI Pharma AB publishes the annual report for the fiscal year 2021/2022
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
25. Nov. 20221 Min. Lesezeit
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2021/2022
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2021/2022....
ODI Pharma
25. Nov. 20221 Min. Lesezeit
ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the...
ODI Pharma
24. Nov. 20221 Min. Lesezeit
Notice to Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
15. Nov. 20225 Min. Lesezeit
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 16 december 2022 kl. 10.30 i bolagets lokaler...
ODI Pharma
15. Nov. 20224 Min. Lesezeit
ODI Pharma AB: Publication of year-end report for the fiscal year 2021/2022
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2021 – June 2022. The report is available...
ODI Pharma
25. Aug. 20224 Min. Lesezeit
ODI Pharma AB: Publication of interim report Q3 2021/2022
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2021 – March 2022. The report is available...
ODI Pharma
25. Mai 20223 Min. Lesezeit
Correction: ODI Pharma AB: Publication of half-year report 2021
Correction: ODI Pharma hereby discloses a revised half-year report for the period July – December 2021. In the previous report, the cost...
ODI Pharma
25. Feb. 20224 Min. Lesezeit
ODI Pharma AB: Publication of half-year report 2021
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2021. The report is available...
ODI Pharma
24. Feb. 20224 Min. Lesezeit
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
13. Dez. 20212 Min. Lesezeit
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 13 december 2021 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
13. Dez. 20212 Min. Lesezeit
ODI Pharma AB: Publication of interim report for the first quarter 2021/2022
ODI Pharma AB (“ODI Pharma” or the “Company”) hereby publishes its interim report concerning the period July 2021 – September 2021. The...
ODI Pharma
25. Nov. 20213 Min. Lesezeit
ODI Pharma AB publishes the annual report for the fiscal year 2020/2021
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
18. Nov. 20211 Min. Lesezeit
Notice to Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
9. Nov. 20214 Min. Lesezeit
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 13 december 2021 kl. 10.00 i bolagets lokaler...
ODI Pharma
9. Nov. 20214 Min. Lesezeit
bottom of page